[1] Castrucci, M.R. and Kawaoka, Y. (1993) Biologic importance of neuraminidase stalk length in influenza A virus. J Virol, 67, 759-764.
[2] Els, M.C., Air, G.M., Murti, K.G. et al. (1985) An 18-amino acid deletion in an influenza neuraminidase. Virology, 142, 241-247.
[3] Zhou, H.B., Yu, Z.J., Hu, Y. Tu, J.G. et al. (2009) The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One, 4(7), 6277.
[4] Wagner, R., Matrosovich, M. and Klenk, H.D. (2002) Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol, 12, 159-166.
[5] Lu, B., Zhou, H.L., Ye, D., Kemble, G. and Jin, H. (2005) Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. Journal of Virology, 79, 6763-6771.
[6] Hu, W. (2009) Analysis of correlated mutations, stalk motifs, and phylogenetic relationship of the 2009 influenza A virus neuraminidase sequences. Journal of Biomedical Science and Engineering, 2, 550-555
[7] Sebastian, M.S., Ma, J.M., Raphael, T.C.L., Fernanda, L. S. and Frank, E. (2009) Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct, 4(18).
[8] Laurel, G., James, S., Dmitriy Z. et al. (2005) A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. Journal of Virology, 79, 11533-11536.
[9] Skehel, J.J., Stevens, D.J., Daniels, R.S., Douglas, A.R., Knossow, M. et al. (1984) A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A, 81, 1779-1783.
[10] Wiley, D.C., Wilson, I.A. and Skehel, J.J. (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature, 289, 373-378.
[11] Caton, A.J., Brownlee, G.G., Yewdell, J.W. and Gerhard, W. (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell, 31, 417-27.
[12] Tsuchiya, E., Sugawara, K., Hongo, S., Matsuzaki, Y., Muraki, Y. et al. (2001) Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J Gen Virol, 82, 2475-2484.
[13] Michael, W.D. and Pan, K.Y. (2009) The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Engineering, Design & Selection, 22, 543-546.
[14] Katoh, K., Kuma, K., Toh, H., Miyata, T. (2005) MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res, 33, 511-518.
[15] David, M. (2003) Information theory, inference, and learning algorithms. Cambridge University Press. Breiman, L. (2001) Random forests, machine learning, 45 (1), 5-32.
[16] Cox, T.F. and Cox, M.A.A. (2001), Multidimensional scaling, chapman and hall.
[17] Colman, P.M., Hoyne, P.A. and Lawrence, M.C. (1993) Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol, 67, 2972-2980.
[18] Andrea, K., Gabriel, R.N. and Ivan, K.H., Sccarontefan, J. (2002) Sequence similarities and evolutionary relationships of influenza virus A hemagglutinins, Virus Genes, 24, 57-63.
[19] Waterhouse, A.M., Procter, J.B., Martin, D.M.A., Clamp, M and Barton, G.J. (2009) Jalview version 2 – A multiple sequence alignment editor and analysis workbench. Bioinformatics, 5, 1189-1191.
[20] Enrique, T. and Mu?noz, M.W.D. (2005) Epitope analysis for influenza vaccine design. Vaccine, 23, 1144-1148.
[21] Weis, W., Brown, J.H., Cusack, S., Paulson, J.C., Skehel, J.J. and Wiley, D.C. (1988) Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature, 333(6172), 426-31.
[22] Veljko, V., Henry, L.N., Sanja G. et al. (2009) Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Structural Biology, 9(62).
[23] Nikolai, V.K., Mikhail, N.M. and Aleksandra, S.G. (2000) Intergenic HA–NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Research, 66,123-129.
[24] Garten, R.J., Davis, C.T., Russell, C.A. et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science, 325, 197-201.
[25] Kumar, S., Nei, M., Dudley, J. and Tamura. K., (2008) MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinformatics, 9, 299-306.
[26] Lu, B., Zhou, H., Ye, D., Kemble, G. and Jin, H., (2005) Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J. Virol, 79, 6763-6771.
[27] Jin, H., Zhou, H., Liu, H., Chan, W.N., Adhikary, L. et al. (2005) Two residues in the hemagglutinin of A/Fujian/ 411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology, 336, 113- 119.
[28] Elodie G., Naomi A.S., Martin S. et al. (2005) Large- scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature, 437, 1162-1166.
[29] Du, X.J., Wang, Z., Wu, A.P., Song, L., Cao, Y., Hang, H.Y. and Jiang, T.J. (2008) Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res, 18, 178-187.
[30] Huang, J.W., King, C.C. and Yang, J.M. (2009) Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics, 10(Suppl 1), S41.
[31] Michel, W., Chen, C.C., Kemp, M.M. and Linhard, R.J. (2009) Synthesis and biological evaluation of non- hydrolyzable 1,2,3-triazole-linked sialic acid derivatives as neuraminidase inhibitors. European Journal of Organic Chemistry, 2009(16), 2587.
[32] Gocn?′k, M., Fislova′, T., Mucha, V., Sla′dkova′, T. et al. (2008) Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. Journal of General Virology, 89, 958-967.